Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Noramco

Noramco
1979 FOUNDED
PRIVATE STATUS
201-300 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceutical ingredients. The company designs, constructs and manage a bulk active pharmaceutical ingredient plant and offers oxycodone, hydrocodone, hydromorphone, oxymorphone, buprenorphine, nal compounds and active ingredients used in painkillers.

Website
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 500 Swedes Landing Raod
  • Wilmington, DE 19801
  • United States

+1 (302) 000-0000

Noramco Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Noramco‘s full profile, request access.

Request full access to PitchBook

Noramco Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Noramco‘s full profile, request access.

Request full access to PitchBook

Noramco Executive Team (6)

Name Title Board
Seat
Contact
Info
Jim Mish Chief Executive Officer & President
Alan Majewski Chief Financial Officer

4 Former Executives

You’re viewing 2 of 6 executives. Get the full list »